OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
12
Results
Show all
Save search
Copy query
Show results for
Unknown
(12)
Publication Date
Release Date
2020
(3)
2022
(2)
2021
(2)
2019
(2)
2025
(1)
2023
(1)
2017
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Luminescent Citrate-Functionalized Terbium-Substituted Carbonated Apatite Nanomaterials: Structural Aspects, Sensitized Luminescence, Cytocompatibility, and Cell Uptake Imaging.
Not available
S-EPMC9032902
|
biostudies-literature
Cite
Targeted Gene Delivery Therapies for Cervical Cancer.
Not available
S-EPMC7281413
|
biostudies-literature
Cite
Large-Scale Production of Lentiviral Vectors: Current Perspectives and Challenges.
Not available
S-EPMC7693937
|
biostudies-literature
Cite
Phenformin as an Anticancer Agent: Challenges and Prospects.
Not available
S-EPMC6651400
|
biostudies-literature
Cite
Benzoxazine-Purine Hybrids as Antiproliferative Agents: Rational Design and Divergent Mechanisms of Action.
Not available
S-EPMC12567375
|
biostudies-literature
Cite
Validation of suitable normalizers for miR expression patterns analysis covering tumour heterogeneity.
Not available
S-EPMC5209713
|
biostudies-literature
Cite
LdrB Toxin with In Vitro and In Vivo Antitumor Activity as a Potential Tool for Cancer Gene Therapy.
Not available
S-EPMC6678987
|
biostudies-literature
Cite
Anti-Cancerous Potential of Polysaccharides Derived from Wheat Cell Culture.
Not available
S-EPMC9147229
|
biostudies-literature
Cite
Design, synthesis, HER2 inhibition and anticancer evaluation of new substituted 1,5-dihydro-4,1-benzoxazepines.
Not available
S-EPMC8279156
|
biostudies-literature
Cite
Metabolomic profile of cancer stem cell-derived exosomes from patients with malignant melanoma.
Not available
S-EPMC7858120
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets